ALV 317 (Nevirapine Extended Release 400 mg)
Pill with imprint ALV 317 is White, Capsule-shape and has been identified as Nevirapine extended release 400 mg. It is supplied by Alvogen Inc..
Nevirapine is used in the treatment of hiv infection; reduction of perinatal transmission of hiv and belongs to the drug class NNRTIs. There is no proven risk in humans during pregnancy. Nevirapine 400 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for ALV 317
Nevirapine extended release
- Imprint:
- ALV 317
- Strength:
- 400 mg
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- NNRTIs
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Alvogen Inc.
- National Drug Code (NDC):
- 47781-0317
More about nevirapine
- Nevirapine Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 3 Reviews
- Drug class: NNRTIs
Consumer resources
- Nevirapine
- Nevirapine Extended-Release Tablets
- Nevirapine Oral Suspension
- Nevirapine Tablets
- Nevirapine (Advanced Reading)
Other brands: Viramune, Viramune XR
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
